logo

NVO

Novo Nordisk
--
--(--)
Market Open: --
--
--(--)
Post-Market: --

NVO fundamentals

Novo Nordisk (NVO) expects to report earnings on Aug 6, 2025, with estimated revenue of 12.11B (YoY +23.92%), and EPS at 0.951736 (YoY +47.25%).
Revenue estimate / YoY
12.11B
+23.92%
EPS estimate / YoY
0.951736
+47.25%
Report date
Aug 6, 2025
EPS
Revenue

Revenue & Expenses

NVO has released its 2025 Q1 earnings report, with revenue of 11.30B, reflecting a YoY change of 19.49%, and net profit of 4.20B, showing a YoY change of 14.28%. The Sankey diagram below clearly presents NVO's revenue sources and cost distribution.

Key Indicators

Novo Nordisk (NVO) key financial stats and ratios, covering profitability, financial health, and leverage.
Novo Nordisk (NVO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Novo Nordisk (NVO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Novo Nordisk (NVO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Novo Nordisk (NVO) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Novo Nordisk (NVO) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield